Rising Pharmaceuticals launches Edetate calcium disodium injectionEdetate calcium disodium injection is prescribed to reduce blood lead levels in both pediatric and adult populations. Teva to pay $225M, Glenmark to pay $30M to settle price fixing chargesGeneric drug makers Teva and Glenmark have agreed to divest their generic Pravachol business. Organon achieves national formulary access for Hadlima Hadlima is a tumor necrosis factor blocker indicated for patients with a variety of conditions. GRx+Bosims 2023 to feature FDA Commissioner Robert Califf FDA Commissioner Robert Califf will be the keynote FDA speaker during a “Fireside Chat” at GRx+Bosims 2023, which will be held Oct. 2-4. Upsher-Smith debuts generic Apriso Apriso is indicated for the maintenance of remission of ulcerative colitis in adults. Alembic makes executive appointment Nilesh Wadhwa, head of international business and strategy, has been designated as senior management personnel. Fresenius Kabi, Formycon secure U.S. license date for proposed Stelara biosimilar The proposed Stelara biosimilar is a human monoclonal antibody for treatment of immune-mediated disorders. Lupin launches generic HandiHaler, receives FDA OK for 2 generics The company also has received FDA approval for generic Toprol-XL tablets and generic Bromday. Novartis spin-off of Sandoz generics drug unit to occur on or around Oct. 4 Novartis said it is confident that the spin-off is in the best interests of shareholders. Xiromed launches first generic of Balcoltra Xiromed's Joyeaux is an oral contraceptive. First Previous 47 48 49 50 51 Next Last
